Related Experiment Video

Updated: Jun 2, 2026

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
10:53

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method

Published on: February 26, 2018

Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons

Vu C Dang1, MacDonald J Christie1

  • 1Department of Psychiatry, University of California, San Francisco, CA, USABrain & Mind Research Institute, University of Sydney, NSW, Australia.

British Journal of Pharmacology
|May 14, 2011
PubMed

Insights

Novel opioid agonists offer pain relief but can cause tolerance. Understanding how different opioids affect µ-opioid receptor (MOR) regulation, particularly β-arrestin-2 involvement, is key to developing less tolerance-inducing analgesics.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Opioid agonists targeting µ-opioid receptors (MOR) are effective analgesics but can lead to tolerance with prolonged use.
  • Developing novel opioid agonists that maintain analgesic efficacy while minimizing tolerance is a significant challenge in pain management.
  • Different MOR agonists exhibit varying abilities to engage downstream signaling pathways and initiate receptor regulatory events.

Purpose of the Study:

  • To review current understanding of differential MOR regulation by various opioid agonists.
  • To examine the roles of MOR phosphorylation, β-arrestin binding, and receptor trafficking in opioid tolerance.
  • To explore how recent evidence challenges existing models of MOR desensitization and resensitization.

Main Methods:

  • Review of existing literature on MOR signaling and regulation.
  • Analysis of studies investigating the effects of different opioid agonists (e.g., DAMGO, morphine) on MOR phosphorylation, β-arrestin binding, and endocytosis.
  • Examination of data from opioid-treated animal models.

Main Results:

  • Opioid agonists differentially regulate MOR, with some (e.g., DAMGO) effectively triggering regulatory events, while others (e.g., morphine) do so poorly.
  • Recent evidence indicates MOR dephosphorylation and resensitization do not necessitate receptor endocytosis.
  • Impaired MOR-effector coupling in chronic opioid exposure may stem from enhanced desensitization and β-arrestin-2-dependent impaired resensitization.

Conclusions:

  • Existing models linking β-arrestin-2 binding and receptor endocytosis to MOR desensitization/resensitization require re-evaluation.
  • Understanding the nuanced mechanisms of MOR regulation by different opioids is crucial for designing analgesics with reduced tolerance potential.
  • Targeting specific MOR regulatory pathways could lead to the development of more effective and safer pain management therapies.

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...